{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:48:20Z","timestamp":1759340900610,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40268-020-00300-9","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T12:17:46Z","timestamp":1584533866000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-6530","authenticated-orcid":false,"given":"Dario","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Sollima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Meraviglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Minisci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Fusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Filice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gervasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"300_CR1","doi-asserted-by":"publisher","first-page":"12311","DOI":"10.3748\/wjg.v21.i43.12311","volume":"21","author":"D Joshi","year":"2015","unstructured":"Joshi D, Agarwal K. Role of liver transplantation in human immunodeficiency virus positive patients. World J Gastroenterol. 2015;21:12311\u201321.","journal-title":"World J Gastroenterol"},{"key":"300_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/MOT.0000000000000199","volume":"20","author":"AA Kardashian","year":"2015","unstructured":"Kardashian AA, Price JC. Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant. 2015;20:276\u201385.","journal-title":"Curr Opin Organ Transplant"},{"key":"300_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/QCO.0000000000000327","volume":"30","author":"E Elliot","year":"2017","unstructured":"Elliot E, Chirwa M, Boffito M. How recent findings on the pharmacokinetics and pharmacodynamics of integrase inhibitors can inform clinical use. Curr Opin Infect Dis. 2017;30:58\u201373.","journal-title":"Curr Opin Infect Dis"},{"key":"300_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40262-016-0424-1","volume":"56","author":"AT Podany","year":"2017","unstructured":"Podany AT, Scarsi KK, Fletcher CV. Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors. Clin Pharmacokinet. 2017;56:25\u201340.","journal-title":"Clin Pharmacokinet"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/0956462419829989","volume":"30","author":"HR Jimenez","year":"2019","unstructured":"Jimenez HR, Natali KM, Zahran AAR. Drug interaction after ritonavir discontinuation: considerations for antiretroviral therapy changes in renal transplant recipients. Int J STD AIDS. 2019;30:710\u20134.","journal-title":"Int J STD AIDS"},{"key":"300_CR6","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2017.0013","author":"M Y\u0131lmaz","year":"2017","unstructured":"Y\u0131lmaz M, G\u00f6kengin D, Bozb\u0131y\u0131k O, Ho\u015fco\u015fkun C, Uyan A, T\u00f6z H. Kidney transplant in a human immunodeficiency virus-positive patient: case report of drug interactions. Exp Clin Transplant. 2017. https:\/\/doi.org\/10.6002\/ect.2017.0013.","journal-title":"Exp Clin Transplant."},{"key":"300_CR7","doi-asserted-by":"crossref","unstructured":"Ambaraghassi G, Cardinal H, Corsilli D, Fortin C, Fortin MC, Martel-Laferri\u00e8re V, Malaise J, P\u00e2quet MR, Rouleau D. First Canadian case report of kidney transplantation from an HIV-positive donor to an HIV-positive recipient. Can J Kidney Health Dis. 2017;4:2054358117695792 (eCollection 2017).","DOI":"10.1177\/2054358117695792"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/tid.12545","volume":"18","author":"DH Lee","year":"2016","unstructured":"Lee DH, Malat GE, Bias TE, Harhay MN, Ranganna K, Doyle AM. Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient. Transpl Infect Dis. 2016;18:625\u20137.","journal-title":"Transpl Infect Dis"},{"key":"300_CR9","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1002\/phar.1752","volume":"36","author":"Z Han","year":"2016","unstructured":"Han Z, Kane BM, Petty LA, Josephson MA, Sutor J, Pursell KJ. Cobicistat significantly increases tacrolimus serum concentrations in a renal transplant recipient with human immunodeficiency virus infection. Pharmacotherapy. 2016;36:e50\u20133.","journal-title":"Pharmacotherapy"},{"key":"300_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/0956462417734099","volume":"29","author":"B Wang","year":"2018","unstructured":"Wang B, Abbott L, Childs K, Taylor C, Agarwal K, Cormack I, Miquel R, Suddle A. Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: a case report and review of literature. Int J STD AIDS. 2018;29:414\u20137.","journal-title":"Int J STD AIDS"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1432-2277.2009.00995.x","volume":"23","author":"K Krejc\u00ed","year":"2010","unstructured":"Krejc\u00ed K, Tich\u00fd T, Hrub\u00fd M, Hor\u00e1k P, Cifersk\u00e1 H, Horcicka V, Strebl P, Al-Jabry S, Bachleda P, Zadrazil J. Subclinical toxicity of calcineurin inhibitors in repeated protocol biopsies: an independent risk factor for chronic kidney allograft damage. Transpl Int. 2010;23:364\u201373.","journal-title":"Transpl Int"},{"key":"300_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.trre.2013.04.003","volume":"27","author":"D Rush","year":"2013","unstructured":"Rush D. The impact of calcineurin inhibitors on graft survival. Transplant Rev (Orlando). 2013;27:93\u20135.","journal-title":"Transplant Rev (Orlando)"},{"key":"300_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/jac\/dkx461","volume":"73","author":"A Palazzo","year":"2018","unstructured":"Palazzo A, Trunfio M, Pirriatore V, Milesi M, De Nicol\u00f2 A, Alcantarini C, D'Avolio A, Bonora S, Di Perri G, Calcagno A. Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid. J Antimicrob Chemother. 2018;73:826\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"300_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jiac.2017.12.022","volume":"24","author":"S Hikasa","year":"2018","unstructured":"Hikasa S, Sawada A, Seino H, Shimabukuro S, Hideta K, Uwa N, Higasa S, Tokugawa T, Kimura T. A potential drug interaction between phenobarbital and dolutegravir: a case report. J Infect Chemother. 2018;24:476\u20138.","journal-title":"J Infect Chemother"},{"key":"300_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/135965350801300516","volume":"13","author":"F Pea","year":"2008","unstructured":"Pea F, Tavio M, Pavan F, Londero A, Bresadola V, Adani GL, Furlanut M, Viale P. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. Antivir Ther. 2008;13:739\u201342.","journal-title":"Antivir Ther"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00300-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-020-00300-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00300-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T02:14:37Z","timestamp":1666145677000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-020-00300-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s40268-020-00300-9","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"type":"print","value":"1174-5886"},{"type":"electronic","value":"1179-6901"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"18 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dario Cattaneo, Salvatore Sollima, Paola Meraviglia, Laura Milazzo, Davide Minisci, Marta Fusi, Carlo Filice and Cristina Gervasoni declare no potential conflicts of interest with respect to the research, authorship and\/or publications of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was conducted using data collected for clinical purposes, all of which had been previously made anonymous in accordance with the requirements of the Italian Personal Data Protection Code (Legislative Decree No. 196\/2003) and the general authorizations issued by the Italian Data Protection Authority.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}